These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3461855)
1. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines. Kaplinsky C; Estrov Z; Freedman MH; Cohen A Blood Cells; 1986; 11(3):459-68. PubMed ID: 3461855 [TBL] [Abstract][Full Text] [Related]
2. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies. Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies. Stöckbauer P; Malasková V; Soucek J; Chudomel V Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor. Matsui T; Nakao Y; Koizumi T; Katakami Y; Fujita T Cancer Res; 1986 Feb; 46(2):583-7. PubMed ID: 3606750 [TBL] [Abstract][Full Text] [Related]
5. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes. Santoli D; Francis MK; Matera L; Ferrero D J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106 [TBL] [Abstract][Full Text] [Related]
6. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells. Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994 [TBL] [Abstract][Full Text] [Related]
7. Changes in cell surface glycoproteins and antigens during differentiation of the human myeloid leukemia cell lines ML-1, ML-2, and HL-60. Stöckbauer P; Gahmberg CG; Andersson LC Cancer Res; 1985 Jun; 45(6):2821-6. PubMed ID: 3857122 [TBL] [Abstract][Full Text] [Related]
8. Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. Harris PE; Ralph P; Gabrilove J; Welte K; Karmali R; Moore MA Cancer Res; 1985 Jul; 45(7):3090-5. PubMed ID: 2988760 [TBL] [Abstract][Full Text] [Related]
9. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856 [TBL] [Abstract][Full Text] [Related]
10. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid. Paukovits JB; Paukovits WR; Laerum OD Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696 [TBL] [Abstract][Full Text] [Related]
11. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells. Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820 [TBL] [Abstract][Full Text] [Related]
13. Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation. Miller LJ; Schwarting R; Springer TA J Immunol; 1986 Nov; 137(9):2891-900. PubMed ID: 2428876 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells. Kohlhepp EA; Condon ME; Hamburger AW Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells. Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050 [TBL] [Abstract][Full Text] [Related]
17. Differentiation antigens of HL-60 promyelocytes during induced maturation. Chiao JW; Wang CY Cancer Res; 1984 Mar; 44(3):1031-3. PubMed ID: 6581865 [TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor. Imaizumi M; Uozumi J; Breitman TR Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018 [TBL] [Abstract][Full Text] [Related]
19. [In vitro differentiation of leukaemic promyelocytes (HL-60): effect on beta-adrenergic receptors and adenylate cyclase activity]. Paietta E Wien Klin Wochenschr; 1983 May; 95(10):336-44. PubMed ID: 6310899 [TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Jiang H; Lin J; Su ZZ; Collart FR; Huberman E; Fisher PB Oncogene; 1994 Nov; 9(11):3397-406. PubMed ID: 7936668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]